Table 2.
Acute adverse events recorded during concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: allergy/immunology
| Grade | Allergic reactions | Highest | |
|---|---|---|---|
| Cohort 1 |
1 |
1 |
1 |
| 2 |
0 |
0 |
|
| 3 |
0 |
0 |
|
| Cohort 2 |
1 |
0 |
0 |
| 2 |
1 |
1 |
|
| 3 | 2 | 2 |